Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases.
Bollen, L
Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases. [electronic resource] - Clinical & experimental metastasis Jan 2015 - 1-5 p. digital
Publication Type: Journal Article; Multicenter Study
1573-7276
10.1007/s10585-014-9685-y doi
Biomarkers, Tumor--metabolism
Disease-Free Survival
Female
Humans
Middle Aged
Phenotype
Receptor, ErbB-2--metabolism
Receptors, Estrogen--metabolism
Receptors, Progesterone--metabolism
Retrospective Studies
Spinal Neoplasms--mortality
Triple Negative Breast Neoplasms--metabolism
Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases. [electronic resource] - Clinical & experimental metastasis Jan 2015 - 1-5 p. digital
Publication Type: Journal Article; Multicenter Study
1573-7276
10.1007/s10585-014-9685-y doi
Biomarkers, Tumor--metabolism
Disease-Free Survival
Female
Humans
Middle Aged
Phenotype
Receptor, ErbB-2--metabolism
Receptors, Estrogen--metabolism
Receptors, Progesterone--metabolism
Retrospective Studies
Spinal Neoplasms--mortality
Triple Negative Breast Neoplasms--metabolism